CardiOCare's project logo

An Interdisciplinary Approach for the Management of the Elderly Multimorbid Patient with Breast Cancer Therapy Induced Cardiac Toxicity

News

Paper accepted in ISBI 2023

Paper accepted in ISBI 2023

Our paper entitled "Automated Left Ventricular Ejection Fraction Measurement in 2D Echocardiography using Deep Learning-based Segmentation" was accepted in ISBI 2023 that will be held in Colombia, in April 2023. Really glad to participate!

read more
New review paper on automatic pain assessment

New review paper on automatic pain assessment

Our review entitled "Automatic assessment of pain based on deep learning methods: A systematic review" has been published in Computer Methods and Programs in Biomedicine journal. The models, the methods, and the types of data employed in establishing the foundation of...

read more
CARDIOCARE in EBCC13

CARDIOCARE in EBCC13

CARDIOCARE, represented by Grigoris Grigoriadis from the University of Ioannina, participated in the 13th European Breast Cancer Conference (EBCC13) with a poster presentation entitled "A multimodal approach for the management of co-morbid cardiotoxicity in the...

read more
CARDIOCARE in IEEE BHI-BSN 2022 in Ioannina

CARDIOCARE in IEEE BHI-BSN 2022 in Ioannina

The Special Session "Artificial intelligence and Real World data for personalized support of patients with cardiovascular diseases" took place successfully on Friday, 30 September at the IEEE BHI-BSN conference. The Special Session concerned artificial intelligence...

read more
New review paper is published online

New review paper is published online

Our paper entitled "A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research" has been published in the Cardio-oncology...

read more
CARDIOCARE in the ESMO Congress 2022

CARDIOCARE in the ESMO Congress 2022

CARDIOCARE participated in the ESMO Congress 2022 with a poster presentation entitled “Incorporating psycho-social factors in cancer treatment adverse events studies“. Really glad to have participated!...

read more

Highlights